124 related articles for article (PubMed ID: 523001)
1. [Intestinal absorption of Ca47 in chronic renal insufficiency before and after treatment with 1,25 dihydroxycholecalciferol].
Vattimo A
Minerva Med; 1979 Dec; 70(54):3705-7. PubMed ID: 523001
[TBL] [Abstract][Full Text] [Related]
2. Comparison of effects of 1 alpha-hydroxy-vitamin D3 and 1,25-dihydroxy-vitamin D3 in man.
Brickman AS; Coburn JW; Friedman GR; Okamura WH; Massry SG; Norman AW
J Clin Invest; 1976 Jun; 57(6):1540-7. PubMed ID: 932193
[TBL] [Abstract][Full Text] [Related]
3. [Intestinal calcium absorption in the early stage of renal insufficiency and the effect of 5,6-trans-25-OHCC].
Werner E; Malluche HH; Ritz E
Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():1305-7. PubMed ID: 611840
[No Abstract] [Full Text] [Related]
4. [1,25-dihydroxycholecalciferol: a hormonal form of vitamin D3].
Schweiz Med Wochenschr; 1979 Oct; 109(38):1405-9. PubMed ID: 583366
[No Abstract] [Full Text] [Related]
5. [Studies on intestinal 47 Calcium absorption in healthy subjects and patients with chronic renal failure as well as on the significance of vitamin D 3 or 25-hydroxycholecalciferol therapy in renal osteopathy].
Hesch RD; Gerlach W; Henning HV; Emrich D; Scheler F; Kattermann R
Dtsch Med Wochenschr; 1972 Nov; 97(45):1735-8 passim. PubMed ID: 4343379
[No Abstract] [Full Text] [Related]
6. [Calcium phosphate metabolism during therapy with 1,25-dihydroxycholecalciferol [1,25 DHCC (Ro 21/5535)] in patients with advanced kidney insufficiency].
Schulz W; Spiegel P; Gessler U; Delling G
Verh Dtsch Ges Inn Med; 1978; (84):1297-301. PubMed ID: 741953
[No Abstract] [Full Text] [Related]
7. Effect of 25-hydroxy-vitamin D3 on intestinal absorption of calcium in normal man and patients with renal failure.
Colodro IH; Brickman AS; Coburn JW; Osborn TW; Norman AW
Metabolism; 1978 Jun; 27(6):745-53. PubMed ID: 651659
[TBL] [Abstract][Full Text] [Related]
8. Decreased renal function in association with administration of 1,25-dihydroxyvitamin D3 to patients with stable, advanced renal failure.
Christiansen C; Røodbro P; Christensen MS; Naestoft J; Hartnack B; Transbøol I
Contrib Nephrol; 1980; 18():139-46. PubMed ID: 6243527
[TBL] [Abstract][Full Text] [Related]
9. Deterioration of renal function during treatment of chronic renal failure with 1,25-dihydroxycholecalciferol.
Christiansen C; Rødbro P; Christensen MS; Hartnack B; Transbøl I
Lancet; 1978 Sep; 2(8092 Pt 1):700-3. PubMed ID: 80633
[TBL] [Abstract][Full Text] [Related]
10. [Parathormone and vitamin d3-metabolites in healthy children and children with chronic renal failure before and after kidney transplantation].
Pistor K; Reinhardt D; Grosse-Hohmann E; Keck E
Monatsschr Kinderheilkd; 1982 Sep; 130(9):714-20. PubMed ID: 6755227
[TBL] [Abstract][Full Text] [Related]
11. Effect of 1,25(OH)2D3 and 24,25(OH)2D3 on experimental rickets.
Kraft D; Offermann G; Steldinger R; Gawlik D
Res Commun Chem Pathol Pharmacol; 1979 Dec; 26(3):571-80. PubMed ID: 523788
[TBL] [Abstract][Full Text] [Related]
12. Effects of long-term therapy with calcitriol in patients with moderate renal failure.
Healy MD; Malluche HH; Goldstein DA; Singer FR; Massry SG
Arch Intern Med; 1980 Aug; 140(8):1030-3. PubMed ID: 6893118
[TBL] [Abstract][Full Text] [Related]
13. Calcitriol in disorders of bone and calcium metabolism.
Riggs BL
Clin Ther; 1980; 3(1):33-9. PubMed ID: 6893296
[No Abstract] [Full Text] [Related]
14. [Clinical importance of disorders of vitamin D metabolism].
Flury W
Schweiz Med Wochenschr; 1978 Jan; 108(4):129-33. PubMed ID: 341302
[TBL] [Abstract][Full Text] [Related]
15. [Effect of 1,25-dihydroxycholecalciferol in renal osteopathy].
Reutter FW; Sieber R; Olah AJ; Dambacher MA
Schweiz Med Wochenschr; 1979 Dec; 109(47):1880-3. PubMed ID: 531567
[TBL] [Abstract][Full Text] [Related]
16. [Comparative study of the effects of alpha-25-dihydroxycholecalciferol and 24, 25-dihydroxycholecalciferol on calcium-phosphorus metabolism and on bone tissue in experimental kidney insufficiency in rats].
Alekseeva AI; Spirichev VB; Bogoslovskiĭ NA; Kisel'nikova TA
Vopr Med Khim; 1983; 29(5):103-12. PubMed ID: 6606264
[TBL] [Abstract][Full Text] [Related]
17. 1-alpha-hydroxyvitamin D3 in chronic renal failure. A potent analogue of the kidney hormone, 1,25-dihydroxycholecalciferol.
Chan JC; Oldham SB; Holick MF; DeLuca HF
JAMA; 1975 Oct; 234(1):47-52. PubMed ID: 1174223
[TBL] [Abstract][Full Text] [Related]
18. Short-term effects of 1,25-dihydroxycholecalciferol on disordered calcium metabolism of renal failure.
Brickman AS; Coburn JW; Norman AW; Massry SG
Am J Med; 1974 Jul; 57(1):28-33. PubMed ID: 4600292
[No Abstract] [Full Text] [Related]
19. Effects of 1,25-dihydroxycholecalciferol on 47calcium absorption in post-menopausal osteoporosis.
Caniggia A; Vattimo A
Clin Endocrinol (Oxf); 1979 Jul; 11(1):99-103. PubMed ID: 519874
[TBL] [Abstract][Full Text] [Related]
20. [Use of 5,6-trans-25-OH-cholecalciferol in patients needing dialysis with florid renal osteopathy: therapeutic management and treatment results].
Cremer W; Graben N; Merguet P
Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():1307-10. PubMed ID: 611841
[No Abstract] [Full Text] [Related]
[Next] [New Search]